These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10344097)

  • 1. [Pharmacokinetics and safety of trovafloxacin].
    Frías J; de los Angeles Gálvez M
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():36-42; discussion 47-52. PubMed ID: 10344097
    [No Abstract]   [Full Text] [Related]  

  • 2. Trovafloxacin.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):30-1. PubMed ID: 9529517
    [No Abstract]   [Full Text] [Related]  

  • 3. Trovafloxacin: in vitro activity, pharmacokinetics, and clinical experience. Introduction.
    Moellering RC
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):403-4. PubMed ID: 9758282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trovafloxacin].
    Azanza JR; Ollero D; Sádaba B; García Quetglas E
    Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
    Garau J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new way to fight surgical infections. High activity of trovafloxacin, even against anaerobic bacteria].
    Chirurg; 1998 Jun; 69(6 Suppl):1-4. PubMed ID: 9696895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of trovafloxacin: its clinical significance].
    Clara LO; Biglia MA
    Medicina (B Aires); 1999; 59 Suppl 1():17-22. PubMed ID: 10436550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry MJ
    Alcohol Clin Exp Res; 1999 May; 23(5):842-9. PubMed ID: 10371404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.
    Join-Lambert OF; Michéa-Hamzehpour M; Köhler T; Chau F; Faurisson F; Dautrey S; Vissuzaine C; Carbon C; Pechère J
    Antimicrob Agents Chemother; 2001 Feb; 45(2):571-6. PubMed ID: 11158756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.
    Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J
    Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trovafloxacin: an overview.
    Garey KW; Amsden GW
    Pharmacotherapy; 1999 Jan; 19(1):21-34. PubMed ID: 9917076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.
    Peleman RA; Van De Velde V; Germonpré PR; Fleurinck C; Rosseel MT; Pauwels RA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):178-80. PubMed ID: 10602743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tosufloxacin].
    Onodera A; Watanabe A
    Jpn J Antibiot; 1995 Apr; 48(4):441-8. PubMed ID: 7783312
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
    García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
    Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
    Khan AA; Slifer T; Araujo FG; Polzer RJ; Remington JS
    Antimicrob Agents Chemother; 1997 May; 41(5):893-7. PubMed ID: 9145840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quinolones. Introduction].
    Gené RJ; Luna CM
    Medicina (B Aires); 1999; 59 Suppl 1():1-2. PubMed ID: 10436547
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of trovafloxacin therapy in community-acquired pneumonia].
    Luna CM; Gené RJ
    Medicina (B Aires); 1999; 59 Suppl 1():31-8. PubMed ID: 10436552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trovafloxacine--a new quinolone with expanded action spectrum].
    Internist (Berl); 1998 Jun; 39(6 Suppl Trovafloxa):1-4. PubMed ID: 9693682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.